Eli Lilly and Company - ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer
Links shared publicly online about this topic.
- 2,008total visits
Eli Lilly and Company - ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer
Eli Lilly and Company - ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer
View full resource at newsroom.lilly.com
Tags: Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer Medication, Lung, Alimta, Eli Lilly and Company
Most Recently Shared on May 29, 2009 at 6:07 pm By:
ALIMTA(R) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer - http://bit.ly/SGd4i
Advertisement
